Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19
Yoko Shibata,Kenji Omae,Hiroyuki Minemura,Yasuhito Suzuki,Takefumi Nikaido,Yoshinori Tanino,Atsuro Fukuhara,Ryuzo Kanno,Hiroyuki Saito,Shuzo Suzuki,Taeko Ishii,Yayoi Inokoshi,Eiichiro Sando,Hirofumi Sakuma,Tatsuho Kobayashi,Hiroaki Kume,Masahiro Kamimoto,Hideko Aoki,Akira Takama,Takamichi Kamiyama,Masaru Nakayama,Kiyoshi Saito,Koichi Tanigawa,Masahiko Sato,Toshiyuki Kambe,Norio Kanzaki,Teruhisa Azuma,Keiji Sakamoto,Yuichi Nakamura,Hiroshi Ohtani,Mitsuru Waragai,Shinsaku Maeda,Tokiya Ishida,Keishi Sugino,Minoru Inage,Noriyuki Hirama,Kodai Furuyama,Shigeyuki Fukushima,Hiroshi Saito,Jun-Ichi Machiya,Hiroyoshi Machida,Koya Abe,Katsuyoshi Iwabuchi,Yuji Katagiri,Yasuko Aida,Yuki Abe,Takahito Ota,Yuki Ishizawa,Yasuhiko Tsukada,Ryuki Yamada,Riko Sato,Takumi Onuma,Hikaru Tomita,Mikako Saito,Natsumi Watanabe,Mami Rikimaru,Takaya Kawamata,Takashi Umeda,Julia Morimoto,Ryuichi Togawa,Yuki Sato,Junpei Saito,Kenya Kanazawa,Noriaki Kurita,Ken Iseki
DOI: https://doi.org/10.1186/s12890-023-02604-3
2023-08-28
Abstract:Background: During the fifth wave of the coronavirus disease 2019 (COVID-19) pandemic in Japan, which took place between June and September 2021, a significant number of COVID-19 cases with deterioration occurred in unvaccinated individuals < 65 years old. However, the risk factors for COVID-19 deterioration in this specific population have not yet been determined. This study developed a prediction method to identify COVID-19 patients < 65 years old who are at a high risk of deterioration. Methods: This retrospective study analyzed data from 1,675 patients < 65 years old who were admitted to acute care institutions in Fukushima with mild-to-moderate-1 COVID-19 based on the Japanese disease severity criteria prior to the fifth wave. For validation, 324 similar patients were enrolled from 3 hospitals in Yamagata. Logistic regression analyses using cluster-robust variance estimation were used to determine predictors of disease deterioration, followed by creation of risk prediction scores. Disease deterioration was defined as the initiation of medication for COVID-19, oxygen inhalation, or mechanical ventilation starting one day or later after admission. Results: The patients whose condition deteriorated (8.6%) tended to be older, male, have histories of smoking, and have high body temperatures, low oxygen saturation values, and comorbidities, such as diabetes/obesity and hypertension. Stepwise variable selection using logistic regression to predict COVID-19 deterioration retained comorbidities of diabetes/obesity (DO), age (A), body temperature (T), and oxygen saturation (S). Two predictive scores were created based on the optimism-corrected regression coefficients: the DOATS score, including all of the above risk factors, and the DOAT score, which was the DOATS score without oxygen saturation. In the original cohort, the areas under the receiver operating characteristic curve (AUROCs) of the DOATS and DOAT scores were 0.81 (95% confidence interval [CI] 0.77-0.85) and 0.80 (95% CI 0.76-0.84), respectively. In the validation cohort, the AUROCs for each score were both 0.76 (95% CI 0.69-0.83), and the calibration slopes were both 0.80. A decision curve analysis confirmed the clinical practicability of both scores in the validation cohort. Conclusions: We established two prediction scores that can quickly evaluate the risk of COVID-19 deterioration in mild/moderate patients < 65 years old.